Workflow
Wetown Electric(688226)
icon
Search documents
威腾电气集团股份有限公司2025年第三次临时股东会决议公告
证券代码:688226 证券简称:威腾电气 公告编号:2025-064 威腾电气集团股份有限公司 2025年第三次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的 真实性、准确性和完整性依法承担法律责任。 重要内容提示: (三)出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及其持有表决权数量的情 况: ■ (四)表决方式是否符合《公司法》及公司章程的规定,股东会主持情况等。 本次会议由董事会召集,由董事长蒋文功先生主持,会议采取现场投票和网络投票相结合的表决方式。 本次股东会的召集和召开程序、出席会议人员的资格和召集人资格、会议的表决程序和表决结果均符合 《中华人民共和国公司法》(以下简称"《公司法》")及《威腾电气集团股份有限公司章程》(以下简 称"《公司章程》")的规定。 (五)公司董事和董事会秘书的列席情况 1、公司在任董事9人,列席9人; 2、董事会秘书吴波先生列席了本次会议;高级管理人员及公司聘请的律师列席了本次会议。 ● 本次会议是否有被否决议案:无 一、会议召开和出席情况 (一)股东会召开的时间:2025年11月28日 ...
威腾电气(688226) - 威腾电气集团股份有限公司2025年第三次临时股东会决议公告
2025-11-28 09:45
2025年第三次临时股东会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: 本次会议是否有被否决议案:无 一、 会议召开和出席情况 (三) 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况: | 1、出席会议的股东和代理人人数 | 59 | | --- | --- | | 普通股股东人数 | 59 | | 2、出席会议的股东所持有的表决权数量 | 98,683,895 | | 普通股股东所持有表决权数量 | 98,683,895 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 52.5900 | | 例(%) | | | 普通股股东所持有表决权数量占公司表决权数量的比例(%) | 52.5900 | (四) 表决方式是否符合《公司法》及公司章程的规定,股东会主持情况等。 证券代码:688226 证券简称:威腾电气 公告编号:2025-064 威腾电气集团股份有限公司 1、 公司在任董事9人,列席9人; 2、 董事会秘书吴波先生列席了本次会议;高 ...
威腾电气(688226) - 上海市锦天城律师事务所关于威腾电气集团股份有限公司2025年第三次临时股东会的法律意见书
2025-11-28 09:45
上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于威腾电气集团股份有限公司 2025 年第三次临时股东会的 法律意见书 地址:上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话:(86)21-20511000 传真:(86)21-20511999 邮编:200120 致:威腾电气集团股份有限公司 上海市锦天城律师事务所(以下简称"本所")接受威腾电气集团股份有限 公司(以下简称"公司")委托,就公司召开 2025 年第三次临时股东会(以下 简称"本次股东会")的有关事宜,根据《中华人民共和国公司法》(以下简称 "《公司法》")、《上市公司股东会规则》等法律、法规和其他规范性文件以 及《威腾电气集团股份有限公司章程》(以下简称"《公司章程》")的有关规 定,出具本法律意见书。 上海市锦天城律师事务所 关于威腾电气集团股份有限公司 2025 年第三次临时股东会的法律意见书 为出具本法律意见书,本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则》等规定,严格履行了法定职 责,遵循了勤勉尽责和诚实信用原则,对本次股东会所涉及的相关事项进行了 ...
深圳市英威腾电气股份有限公司 第七届董事会第十四次会议决议公告
Core Viewpoint - Shenzhen Invt Electric Co., Ltd. has convened its 14th meeting of the 7th Board of Directors, where several financial proposals were approved to enhance operational efficiency and manage financial resources effectively [1][2]. Group 1: Financial Proposals - The company plans to apply for a comprehensive credit limit of up to RMB 2.75 billion from financial institutions to meet operational funding needs [2]. - The company approved the use of idle funds to purchase low-risk bank financial products, with a total investment limit not exceeding RMB 500 million [11][12]. - The company will engage in asset pool and bill pool business with a limit of up to RMB 500 million, aimed at improving liquidity and financial asset management [23][27]. - The company will conduct foreign exchange derivative trading to mitigate foreign exchange market risks, with a maximum trading margin of RMB 50 million and a maximum contract value of RMB 500 million [35][36]. - The company will initiate accounts receivable factoring business with a financing limit of up to RMB 500 million to accelerate cash flow and improve financial structure [51][56]. - The company will undertake financing leasing business with a limit of up to RMB 200 million to meet operational funding needs [62][65]. Group 2: Meeting Details - The 14th meeting was held on November 26, 2025, with all 9 directors present, ensuring compliance with legal and regulatory requirements [1][2]. - The company will hold a temporary shareholders' meeting on December 15, 2025, to review the proposals that require shareholder approval [8][9].
威腾电气前3季净利降87% A股募8亿IPO中信证券保荐
Zhong Guo Jing Ji Wang· 2025-11-21 08:17
中国经济网北京11月21日讯 威腾电气(688226.SH)日前发布2025年三季度报告。2025年前三季度, 该公司实现营业收入25.97亿元,同比下降5.40%;实现归属于上市公司股东的净利润1366.32万元,同比下 降87.47%;实现归属于上市公司股东的扣除非经常性损益的净利润1014.48万元,同比下降90.42%;经营活 动产生的现金流量净额为-9997.67万元。 | 项目 | 本报告期 | 本报告期比 上年同期增 减变动幅度 | 年初至报告期末 | 年初至报告期 末比上年同期 增减变动幅度 | | --- | --- | --- | --- | --- | | | | (%) | | (%) | | 雪业收入 | 864.678.681.91 | -3.15 | 2,596,797,822.98 | -5.40 | | 到海总额 | -3.005.146.49 | -107.86 | 13.744.958.47 | -89.89 | | 目属于上市公司股东的 | -2.822.691.69 | -109.33 | 13.663.236.06 | -87.47 | | 争利润 | | | | ...
威腾电气(688226) - 威腾电气集团股份有限公司2025年第三次临时股东会会议资料
2025-11-21 08:00
威腾电气集团股份有限公司 2025年第三次临时股东会会议资料 证券代码:688226 证券简称:威腾电气 威腾电气集团股份有限公司 2025 年第三次临时股东会会议资料 二〇二五年十一月 1 | 年第三次临时股东会会议议程 5 2025 | | | --- | --- | | 2025 年第三次临时股东会会议议案 7 | | | 议案一:关于前次募集资金使用情况专项报告的议案 | 7 | | 及相关主体承诺事项的议案 | 8 | | 议案三:关于制定公司未来三年(2025-2027 年)股东分红回报规划的议案 9 | | 威腾电气集团股份有限公司 2025年第三次临时股东会会议资料 威腾电气集团股份有限公司 2025 年第三次临时股东会会议须知 为保障威腾电气集团股份有限公司(以下简称"公司"或"本公司")全体股 东的合法权益,维护股东会的正常秩序,确保股东会如期、顺利召开,根据《中 华人民共和国公司法》(以下简称"《公司法》")《中华人民共和国证券法》 (以下简称"《证券法》")《上市公司股东会规则》《威腾电气集团股份有限 公司章程》(以下简称"《公司章程》")以及《威腾电气集团股份有限公司股 东会议事规则 ...
深圳市英威腾电气股份有限公司 关于全资子公司完成工商变更登记的公告
证券代码:002334 证券简称:英威腾 公告编号:2025-055 深圳市英威腾电气股份有限公司 关于全资子公司完成工商变更登记的公告 本公司及董事会全体成员保证公告披露的内容真实、准确和完整,不存在虚假记载、误导性陈述或者重 大遗漏。 近日,深圳市英威腾电气股份有限公司的全资子公司中山市英威腾精密技术有限公司对其住所进行了变 更,并于近日完成了工商变更登记手续,取得新的《营业执照》,变更后的基本信息如下: 4、类型:有限责任公司(非自然人投资或控股的法人独资) 5、成立日期:2021年12月01日 6、法定代表人:黄秋林 7、住所:中山市三角镇汇智路3号4栋1-2层。 8、经营范围:一般项目:五金产品研发;五金产品制造;五金产品零售;专用设备制造(不含许可类专 业设备制造);金属制品研发;金属制品销售;通用设备制造(不含特种设备制造);机械设备研发;机械 设备销售。(除依法须经批准的项目外,凭营业执照依法自主开展经营活动) 特此公告。 深圳市英威腾电气股份有限公司董事会 2025年11月19日 1、名称:中山市英威腾精密技术有限公司 2、统一社会信用代码 :91442000MAA4H37393 3、注册资 ...
威腾电气11月14日获融资买入1691.56万元,融资余额4.87亿元
Xin Lang Cai Jing· 2025-11-17 01:27
Core Insights - On November 14, Weiteng Electric experienced a decline of 0.45% with a trading volume of 218 million yuan, indicating a negative net financing buy of 10.31 million yuan for the day [1] - As of September 30, Weiteng Electric reported a revenue of 2.597 billion yuan, a year-on-year decrease of 5.40%, and a net profit attributable to shareholders of 13.6632 million yuan, down 87.47% year-on-year [2] Financing and Margin Trading - On November 14, Weiteng Electric had a financing buy of 16.9156 million yuan, with a total financing balance of 487 million yuan, accounting for 7.37% of its market capitalization, which is above the 70th percentile of the past year [1] - The margin trading data shows that there were no shares sold or repaid on November 14, with a margin balance of 0 yuan, indicating a high level of margin trading activity [1] Shareholder and Dividend Information - As of September 30, the number of Weiteng Electric's shareholders increased by 41.51% to 7,592, while the average circulating shares per person decreased by 15.89% to 24,716 shares [2] - Since its A-share listing, Weiteng Electric has distributed a total of 106 million yuan in dividends, with 86.554 million yuan distributed over the past three years [3]
威腾电气股价跌5.28%,泉果基金旗下1只基金位居十大流通股东,持有290.07万股浮亏损失577.23万元
Xin Lang Cai Jing· 2025-11-13 06:05
Group 1 - The core point of the news is that Weiteng Electric's stock price has dropped by 5.28% to 35.67 CNY per share, with a trading volume of 141 million CNY and a turnover rate of 2.06%, resulting in a total market capitalization of 6.693 billion CNY [1] - Weiteng Electric, established on January 7, 2004, and listed on July 7, 2021, is primarily engaged in the research, manufacturing, and sales of busbar products. The main revenue composition includes: photovoltaic new materials (photovoltaic welding strips) 46.68%, distribution equipment (high and low voltage busbars) 25.26%, energy storage systems 21.46%, and others [1] Group 2 - From the perspective of the top ten circulating shareholders, a fund under Quanguo Fund holds a position in Weiteng Electric. The Quanguo Xuyuan Three-Year Holding Period Mixed A Fund (016709) reduced its holdings by 463,500 shares in the third quarter, now holding 2.9007 million shares, accounting for 1.55% of circulating shares. The estimated floating loss today is approximately 5.7723 million CNY [2] - The Quanguo Xuyuan Three-Year Holding Period Mixed A Fund, managed by Zhao Yi, was established on October 18, 2022, with a latest scale of 16.329 billion CNY. Year-to-date returns are 46.71%, ranking 1163 out of 8145 in its category, while the one-year return is 30.57%, ranking 1935 out of 8059 [2]
11月12日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-12 10:24
Group 1 - Longjian Co., Ltd. won a bid for a highway maintenance project in Heilongjiang with a contract value of 483 million yuan, accounting for 2.64% of the company's expected revenue for 2024 [1] - Transsion Holdings plans to issue H-shares and list on the main board of the Hong Kong Stock Exchange [1] - Good Home's controlling shareholder intends to reduce its stake by up to 2.7%, equivalent to no more than 39.4468 million shares [1][2] Group 2 - Xinhua Insurance reported a cumulative premium income of 181.973 billion yuan from January to October, representing a year-on-year growth of 17% [2][4] - Zhejiang Jiaokao is part of a consortium that plans to bid for a new urbanization project with an estimated total investment of 11.103 billion yuan [4] Group 3 - Changchun High-tech received approval for clinical trials of a vaccine for adolescents and adults [6] - XinNuoWei's application for the listing of Pertuzumab injection has been accepted, targeting HER2-positive breast cancer [8] - Dash Smart won a bid for an intelligent project at the new Huanggang Port inspection building, valued at 55.056 million yuan, which is 1.74% of its expected revenue for 2024 [8] Group 4 - Electronic City is involved in a lawsuit for debt recovery, with the amount in dispute estimated at 777 million yuan [9] - Haibo Technology signed a strategic cooperation agreement with CATL for a cumulative procurement of no less than 200 GWh of electricity from 2026 to 2028 [10] Group 5 - Renfu Pharmaceutical's HW231019 tablets have entered the second phase of clinical trials for postoperative pain relief [11] - Tonghua Dongbao received a drug registration certificate for Aspart Insulin injection from the Dominican Republic [11] Group 6 - Shaanxi Construction reported winning major projects worth a total of 1.016 billion yuan in October [12] - Fuzhou Environmental Protection plans to change its stock name to "Fuzhou Technology" [12] Group 7 - Panlong Pharmaceutical's gel patch for knee osteoarthritis has received approval for clinical trials [15] - Zhongyida's application for a specific stock issuance has been terminated by the Shanghai Stock Exchange [16] Group 8 - Zhizhong Home's controlling shareholder reduced its holdings of convertible bonds by 905,000 units, accounting for 13.51% of the total issued [19] - Haibo Co., Ltd. plans to establish a subsidiary with an investment of 1 billion yuan for high-end component projects [21] Group 9 - Caina Co. plans to use 57 million yuan of idle funds to purchase structured deposits [23] - Zhendong Pharmaceutical's new drug for acute ischemic stroke has entered the IIa phase of clinical trials [25] Group 10 - Weiman Sealing's overseas subsidiary plans to lease a factory in Saudi Arabia for 5 years at a total rent of approximately 54.039 million yuan [26] - Yiling Pharmaceutical's application for Memantine Hydrochloride has been approved for market entry [28] Group 11 - Dongfang Zhizao plans to acquire 70% of Saifu Machinery for 27.4887 million yuan [30] - JianKai Technology's actual controller intends to transfer 3% of the company's shares through inquiry [31] Group 12 - Rejing Bio plans to repurchase shares worth between 100 million and 200 million yuan [32] - Bangji Technology has decided to terminate a major asset restructuring project due to failure to reach an agreement [34] Group 13 - Huadong Pharmaceutical's application for the marketing license of a new drug has been accepted [36] - Zhonggu Logistics' shareholder plans to reduce its stake by up to 3% [38] Group 14 - Bohui Innovation's subsidiary received approval for a clinical trial of a vaccine for invasive infections [40] - Shannon Chip's shareholder pledged 0.27% of the company's shares for financing [42] Group 15 - Shanghai Petrochemical appointed a new general manager [44] - Jiaojian Co. plans to reduce the holdings of some directors and executives by up to 0.35% [46] Group 16 - Weiting Electric plans to raise no more than 300 million yuan through a private placement [47] - Zhongjin Irradiation plans to invest approximately 200 million yuan in an electronic accelerator manufacturing project [49] Group 17 - Tongxing Technology signed a framework agreement to invest 3.2 billion yuan in a sodium battery project [50] - Hongri Da plans to establish a subsidiary focused on semiconductor packaging [51] Group 18 - Shanghai Kaibao's new drug for acute ischemic stroke has received approval for clinical trials [53] - Yitong Century announced a change in its control structure, becoming a company without a controlling shareholder [55]